In manufacturer-sponsored trials, investigators have showed that cholinesterase inhibitors produce small improvements in cognitive and functional status in patients with mild-to-moderate Alzheimer ...

July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...

Donepezil, marketed under the brand name Aricept, is an oral tablet medication prescribed for people living with Alzheimer’s disease. Medicare drug plans may cover the brand drug Aricept or its ...

Aricept (donepezil) is a tablet medication prescribed for people living with Alzheimer’s disease. Medicare drug plans may cover Aricept or its generic version, but the exact coverage and a person’s ...